AG
KURA icon

Algert Global’s Kura Oncology KURA Stock Holding History

Algert Global’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-78,215
Closed -$636K – 1339
2026
Q1 		$636K Buy
+78,215
New +$672K 0.01% 939
2025
Q4 		– Sell
-1,011,945
Closed -$8.96M – 1242
2025
Q3 		$8.96M Sell
1,011,945
-58,194
-5% -$415K 0.15% 218
2025
Q2 		$6.17M Buy
1,070,139
+111,647
+12% +$684K 0.13% 262
2025
Q1 		$6.33M Buy
958,492
+74,789
+8% +$583K 0.16% 200
2024
Q4 		$7.7M Buy
883,703
+611,427
+225% +$8.8M 0.18% 171
2024
Q3 		$5.32M Buy
272,276
+11,493
+4% +$233K 0.14% 233
2024
Q2 		$5.37M Sell
260,783
-18,787
-7% -$386K 0.18% 158
2024
Q1 		$5.96M Sell
279,570
-53,880
-16% -$1.05M 0.23% 118
2023
Q4 		$4.8M Sell
333,450
-31,574
-9% -$310K 0.19% 147
2023
Q3 		$3.33M Buy
365,024
+177,959
+95% +$1.81M 0.16% 207
2023
Q2 		$1.98M Buy
187,065
+54,510
+41% +$645K 0.09% 390
2023
Q1 		$1.62M Sell
132,555
-29,361
-18% -$366K 0.08% 421
2022
Q4 		$2.01M Sell
161,916
-21,200
-12% -$308K 0.11% 297
2022
Q3 		$2.5M Buy
183,116
+70,999
+63% +$1.1M 0.15% 206
2022
Q2 		$2.06M Buy
112,117
+20,680
+23% +$297K 0.15% 180
2022
Q1 		$1.47M Buy
91,437
+54,132
+145% +$782K 0.1% 355
2021
Q4 		$522K Sell
37,305
-7,280
-16% -$118K 0.07% 521
2021
Q3 		$835K Buy
44,585
+11,983
+37% +$226K 0.11% 321
2021
Q2 		$680K Sell
32,602
-6,996
-18% -$174K 0.23% 143
2021
Q1 		$1.12M Sell
39,598
-37,150
-48% -$1.18M 0.36% 96
2020
Q4 		$2.51M Buy
76,748
+28,059
+58% +$986K 0.71% 22
2020
Q3 		$1.49M Sell
48,689
-24,857
-34% -$549K 0.47% 66
2020
Q2 		$1.2M Sell
73,546
-8,171
-10% -$118K 0.41% 78
2020
Q1 		$813K Buy
81,717
+52,800
+183% +$604K 0.34% 111
2019
Q4 		$398K Buy
+28,917
New +$428K 0.12% 230

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Algert Global's KURA Position: Q2 2026 in Review

Algert Global sold out of Kura Oncology (KURA) in Q2 2026, closing a stake of 78,215 shares — an estimated $636K sold.

Algert Global first reported a position in KURA in Q4 2019 and held it in 25 quarters. The position peaked at $8.96M in Q3 2025. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Algert Global reported no remaining Kura Oncology position as of Q2 2026 after selling out during the quarter.
  • Algert Global sold 78,215 Kura Oncology shares in Q2 2026, an estimated $636K.
  • Algert Global first reported a position in Kura Oncology in Q4 2019 and held it in 25 quarters.
  • Algert Global's Kura Oncology position peaked at $8.96M in Q3 2025.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.